v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Dec. 31, 2024 $ 44,841   $ 450,986 $ 1 $ (406,146)
Beginning balance, shares at Dec. 31, 2024   3,904,049      
Issuance of common stock upon vesting of restricted stock units, shares   150      
Stock-based compensation 1,637   1,637    
Unrealized (loss) gain on available-for-sale securities (5)     (5)  
Net loss (9,143)       (9,143)
Ending balance at Mar. 31, 2025 37,330   452,623 (4) (415,289)
Ending balance, shares at Mar. 31, 2025   3,904,199      
Beginning balance at Dec. 31, 2024 44,841   450,986 1 (406,146)
Beginning balance, shares at Dec. 31, 2024   3,904,049      
Net loss (16,109)        
Ending balance at Jun. 30, 2025 31,986   454,244 (3) (422,255)
Ending balance, shares at Jun. 30, 2025   3,943,887      
Beginning balance at Mar. 31, 2025 37,330   452,623 (4) (415,289)
Beginning balance, shares at Mar. 31, 2025   3,904,199      
Issuance of common stock upon vesting of restricted stock units, shares   29,688      
Issuance of common stock under employee stock purchase plan 24   24    
Issuance of common stock under employee stock purchase plan, shares   10,000      
Stock-based compensation 1,597   1,597    
Unrealized (loss) gain on available-for-sale securities 1     1  
Net loss (6,966)       (6,966)
Ending balance at Jun. 30, 2025 31,986   454,244 (3) (422,255)
Ending balance, shares at Jun. 30, 2025   3,943,887      
Beginning balance at Dec. 31, 2025 27,790 $ 1 539,548 (4) (511,755)
Beginning balance, shares at Dec. 31, 2025   9,335,913      
Issuance of common stock upon vesting of restricted stock units, shares   57,601      
Reclassification of Sermonix Pre-funded warrant to equity 53,808   53,808    
Stock-based compensation 662   662    
Unrealized (loss) gain on available-for-sale securities (9)     (9)  
Net loss (32,948)       (32,948)
Ending balance at Mar. 31, 2026 49,303 $ 1 594,018 (13) (544,703)
Ending balance, shares at Mar. 31, 2026   9,393,514      
Beginning balance at Dec. 31, 2025 27,790 $ 1 539,548 (4) (511,755)
Beginning balance, shares at Dec. 31, 2025   9,335,913      
Net loss (51,955)        
Ending balance at Jun. 30, 2026 33,595 $ 1 597,313 (9) (563,710)
Ending balance, shares at Jun. 30, 2026   9,421,663      
Beginning balance at Mar. 31, 2026 49,303 $ 1 594,018 (13) (544,703)
Beginning balance, shares at Mar. 31, 2026   9,393,514      
Issuance of common stock under employee stock purchase plan 114   114    
Issuance of common stock under employee stock purchase plan, shares   28,149      
Stock-based compensation 3,181   3,181    
Unrealized (loss) gain on available-for-sale securities 4     4  
Net loss (19,007)       (19,007)
Ending balance at Jun. 30, 2026 $ 33,595 $ 1 $ 597,313 $ (9) $ (563,710)
Ending balance, shares at Jun. 30, 2026   9,421,663